IGF2BP2 Overexpression Indicates Poor Survival in Patients with Acute Myelocytic Leukemia
IGF2BP2 Overexpression Indicates Poor Survival in Patients with Acute Myelocytic Leukemia
About this item
Full title
Author / Creator
He, Xin , Li, Wenlu , Liang, Xiaogong , Zhu, Xuan , Zhang, Lei , Huang, Yu , Yu, Teng , Li, Shu and Chen, Zhigang
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Background/Aims: IGF2BP2 has been reported to serve as an oncogene in various solid cancers. However, the role of IGF2BP2 in acute myelocytic leukemia (AML) is still unknown. Methods: Public databases Gene Omnibus was used to evaluate the expression of IGF2BP2 in AML patients and healthy controls. In addition, primary cells from these two populatio...
Alternative Titles
Full title
IGF2BP2 Overexpression Indicates Poor Survival in Patients with Acute Myelocytic Leukemia
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1159_000495719
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1159_000495719
Other Identifiers
ISSN
1015-8987
E-ISSN
1421-9778
DOI
10.1159/000495719
